Jeff Geschwind, MD: Cancer Drug Innovator Founder of Cage Pharma, Jeff Geschwind, MD, researches cancer metabolism-targeting drugs, focusing on glycolysis inhibition. His work opens new avenues for treating aggressive tumors. https://www.linkedin.com/in/jeff-geschwind-037200174v